The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists, particularly through microdosing protocols, offers a promising therapeutic approach specifically tailored to address the unique metabolic challenges of this life stage
It simply means decisions should be informed rather than casual
But what are the real benefits, and who can truly benefit from this treatment
The study findings support the overall ocular safety of this drug class, as the absolute frequency of events remained very low, occurring in 134 patients (0.065%) in the GLP-1 agonist cohort and 143 patients (0.07%) in the comparator cohort
Certified Nutrition Coach and Certified Master Health Coach How to Exercise Safely While Taking GLP-1 Weight-Loss Drugs, MD Explains GLP-1 medications like semaglutide have gained significant attention over the past few years as effective tools for weight management
For some people, medications provide the jumpstart needed to overcome biological barriers to weight loss, making it easier to establish healthy habits
